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individual tumours) have been expanded;
the 4th section on new approaches is shorter.
The introduction deals with the strategy of
cancer treatment, basic concepts of chemo-
therapy and cancer clinical trials. More
emphasis is laid upon the patient who needs
"a sensitive and understanding physician",
when and when not to treat and upon
restraint in treating the elderly aggressively.
The diagrams are clearer but the admirable
section on types of clinical trials might be
helped by more examples of each.
The utility of the second section, where
drugs are considered individually, has been
improved bythe inclusion ofpharmacokinetic
data. Ftorafer, VM-26, dibromo-mannitrol
and calusterone no longer make it but vinde-
sine and nafoxidine now do. Perhaps the
rider on p. 79, that all doses are given as for
single-agent therapy in fit patients and the
advice on when to reduce dosage should be
more prominently displayed for the unwary.
The third section on the chemotherapy of
individual tumours is now (more usefully) in
alphabetical order rather than by tumour
groups. Despite the fact that two authors are
from Europe, vitually all examples of clinical
trials are from the United States. However,
the comments are nicely balanced; in colorec-
tal cancer, combination chemotherapy "can-
not be recommended for routine therapy"
and in ovarian cancer "controlled studies do
not exist to clearly establish the superiority
of platinum combinations over single agent
therapy". The section on adjuvant chemo-
therapy is tempered by a realism which
matches the recent data.
In the final section on new approaches,
"Immunotherapy" has been ingested by
a section called "Biological Response Modi-
fiers" and other new sections include marrow
transplantation, chemosensitivity testing and
radiosensitisers.
A. HOWELL
Regulatory Functions of Interferons. Ed.
J. VILCEK, I. GRESSER, T. C. MERIGAN
(1980) New York: Academy of Sciences.
641 pp. $124.00.
This book comprises the proceedings of a
largeinternational conference (heldinOctober
1979) under the auspices of the New York
Academy of Sciences and sponsored by 30
pharmaceutical companies, the National
Institue of Allergy and Infectious Diseases
and the National Science Foundation. At
this meeting partial amino-acid sequences of
3 different interferons were disclosed for the
first time. However, much of the data
presented here has appeared elsewhere in the
literature, as specialists in the various
fields will immediately recognize. Despite
the repetition which we have relucantly come
to regard as commonplace amongst published
conferences, the book is useful, not least
because it serves as a interdisciplinary
compendium of interferon research, which is
more extensive than other specialized inter-
feron reviews which have recently become
available.
About 300 contributors have presented
data in this volume, in a total of 58 invited
papers and 38 posters. The main subject areas
covered are: regulatory effects of inter-
ferons on lymphocytes and macrophages;
interferons as lymphokines; mechanisms of
cell-growthinhibitionandanti-tumour action;
genetics of the interferon system; regulatory
effects of interferon in various cells; purifica-
tion and properties of interferons; mole-
cular mechanisms of interferon action;
anti-viral mechanisms at the cellular level;
all of which makes for extensive reading.
Data from clinical trials are specifically
excluded, though much of the information
might be considered as a rationale for such
trials. The publication is up to the usual
high quality of the New York Academy of
Sciences. There is an author index; but no
subject index; inclusion of the latter would




mental Significance. Ed. S. SELL (1980)
Chichester: John Wiley. 541 pp. £26.50 net.
In recent years the relationship between
foetal and cancer tissue has been extended to
the products of tumour cells that can be
anlaysed bybiochemicalandimmunochemical
techniques. These range from cell-surface
markers (foetal or differentiation antigens)
placental products, hormones and isoenzymes
to a multiplicity of products such as CEA,
AFP, lymphocyte markers and nucleic acids
such as tRNA. Most of these are produced in
minute amounts in the adult but in muchBOOK REVIEWS 605
greater quantities in tumours. The pursuit of
biochemical markers of cancer cells which
would allow the unambiguous recognition of
the disease has been for many years the
"'Holy Grail" of experimental and clinical
oncologists. Accordingly, the extent to which
the measurement of such oncodevelopmental
markers has contributed to the diagnosis and
prognosis of human tumours features promi-
nently in this volume. Valuable as they are in
this context, cancer markers do not exist for
the clinician, nor to justify the activities of
scientists who discover them. They must play
an important role in the normal developing
embryo or in adult proliferating tissue. Since
expression of different oncodevelopmental
markers is associated with the various stages
of development of different organs, it is
probable that they serve some useful purpose
at specific stages of development. One
attractive hypothesis is that certain onco-
developmental markers are important for the
identification and recognition ofdifferent cell
types during embryogenesis, or for the timing
ofthe metabolic processesrequiredfororgano-
genesis or differentiation. On this theory our
knowledge of the relationship of the expres-
sion of the markers to the carcinogenic
process may be critical to our understanding
of how carcinogens (chemical and/or viral)
act.
The many contributions in this book (an
exemplary one of its kind) bring these and
other objectives into focus in a series of
excellent reviews.
M. MOORE
Clinical Gynaecologic Oncology. P. J.
DISAIA & W. T. CREASMAN (1981) Toronto:
C. V. Mosby. 478 pp.
This is an eiltirely new North American
text book written by experienced gynae-
cologists with students and non-specialist
medical readers in mind. The length of the
text and the detailed information available
make it a reference book. There are chapters
on all the neoplastic diseases encountered by
a specialist gynaecological oncologist, and,
importantly for these readers, chapters on the
difficult subjects of cancer in pregnancy and
breast disease as well as background informa-
tioIl on gynaecological radiotherapy, chemo-
therapy and tumour immunology. The
illustratioins, particularly thoseinthechapters
on the cervix are good, and the style makes
the text very readable. The book will have to
complete with the established texts on this
subject. It has the inevitable advantage of
being very up-to-date in the references
presented and this, commendably, is not at
the expense oftheolder,establishedliterature.
There is a very real attempt to identify and
discuss the problems in management pre-
sented by some of the diseases (micro-
invasive carcinoma of the cervix, early
carcinoma of the body of the uterus and
advanced carcinoma of the ovary) as well
as clear accounts of the rarer gynaecological
malignancies. The best chapters of the book
are those devoted to the diagnosis and
management of carcinoma of the cervix and
are refreshing fortheirclarity.Thesamestand-
ard is not achieved on corpus, uteri and
ovary, and here European doctors will find
the bias towards North American patterns of
investigation and management less helpful.
This book deserves a place as a library text
for those studying gynaecology and radio-
therapy.
R. HUNTER
Lymphatic System Metastasis. Eds L.
WEISS, H. A. GILBERT & S. C. BALLON
(1981) Boston: G. K. Hall 537 pp. $55.00
This volume, the third in a Metastasis
Monograph series, consists of a series of
articles by over 40 authors, and considers
mainly the clinical, rather than experimental
animal situation. This is perhaps a reflection,
at least in part, ofthe paucity ofgood experi-
mental models for lymphatic dissemination
oftumours, and, as emphasized inthe opening
chapter on general pathophysiology of meta-
stasis, it is impossible to make a general
statement on whether lymph nodes are an
especially favourable or hostile environment
for cancer cells.
Several chapters deal with general con-
siderations of diagnosis, using radiological
imaging, biopsy and dissection, and thera-
peutic considerations involving radiotherapy,
chemotherapy and the rationale of combined
radiotherapy and chemotherapy. Over half
the book is a series of 20 clinical chapters
dealing with metastases within the lymphatic
systemfrom malignancies ofdifferent primary